What is Integrated Biopharma?
Integrated Biopharma, operating within the pharmaceutical and fine chemicals sector, is primarily engaged in the sales and distribution of science-based proprietary products and value-added formulations. The company's diverse product portfolio caters to the nutritional, pharmaceutical, food, and cosmetic industries, offering a range of items including vitamins, amino acids, herbal extracts, over-the-counter (OTC) pharmaceuticals, and excipients. Its offerings also extend to health products such as acerola extract, alpha lipoic acid, suma extract, spirulina powder, Vitamin B12, licorice, quercetin, and garcinia cambogia. This broad scope positions Integrated Biopharma as a key supplier of essential ingredients and finished products within its target markets.
How much funding has Integrated Biopharma raised?
Integrated Biopharma has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Integrated Biopharma
PPP
Public-Private Partnership
What's next for Integrated Biopharma?
The recent major strategic investment into Integrated Biopharma signals a pivotal moment for the company, likely enabling significant advancements in research and development, market penetration, or operational scaling. As an enterprise-level funded entity, Integrated Biopharma is expected to leverage this capital to solidify its market position and potentially explore new product lines or geographical expansions. The strategic nature of this financing suggests a focus on long-term value creation and a commitment from investors to support the company's ambitious growth objectives. Future developments will likely center on the effective deployment of these funds to achieve sustainable competitive advantages and enhance shareholder value.
See full Integrated Biopharma company page
